Former Collingwood boss Jeff Browne says he is now in 'deep remission' and 'firing' after once being told his blood cancer ...

MJF continues his reign over AEW, now preparing for his match against "Hangman" Adam Page, provided he hangs on to the title ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended ...

Changes may be coming to the crypto industry as the Australian government cracks down on platform licensing requirements. You can currently buy cryptocurrency in Australia through exchanges, crypto ...

Multiple Myeloma (MM) in dogs is typically treated with a combination of alkylating agents and corticosteroids. However, treatment failure or intolerance, often due to cumulative toxicities, can limit ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell ...

KLN-1010 is a novel in vivo gene therapy for multiple myeloma, eliminating chemotherapy and ex vivo cell manufacturing, potentially broadening CAR-T therapy access. The FDA's IND clearance allows ...

Dr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover recommendations for therapeutic ...

A recent coaching change provided the necessary boost for Australia to book a sixth straight World Cup spot. Similar to the U.S. in which soccer is behind other more popular sports, the growth of its ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Rochester biotech company ...

New research reveals teclistamab and daratumumab significantly enhance progression-free survival in multiple myeloma, reshaping treatment standards. Maria-Victoria Mateos, MD, PhD, closed out the late ...